- No products in the cart.
Antibacterial triphosphates: different use of nucleoside analogues
August 15, 2022|Antivirals | 5 Min Read
Antibacterial triphosphates: different use of nucleoside analogues1 In the last years, and especially during the SARS-Co-2 pandemic, giant efforts were devoted to designing, synthesising and studying antiviral agents. On the […]
by santiagola
Santiago’s Case Study: Antiviral Kit
April 5, 2022|Antivirals | 4 Min Read
Research in a time of COVID-19 When a thousand people worldwide suffered from lethal coronavirus (COVID-19) in 2020, we came up with an ambitious project to contribute to the worldwide […]
by santiagola
New Nucleoside Triphosphates with Antiviral Activity
February 3, 2022|Antivirals, Triphosphates | 5 Min Read
Nucleoside triphosphates with antiviral activity Viruses are causing many troubles in our lives these days. They cause many serious diseases (some of them even deadly) such as cold, influenza, EBOLA, […]
by santiagola
Antiviral drugs
December 13, 2021|Antivirals, Nucleosides, Triphosphates | 8 Min Read
Viruses are pathogens occurring all around us that can be fought with antiviral drugs. Viruses are the cause of a large number of diseases, many of which are deadly – […]
by santiagola
Molnupiravir
November 19, 2021|Antivirals, Nucleosides, Triphosphates, Uncategorized | 3 Min Read
Molnupiravir is a new potential drug against the SARS-CoV-2 infectious virus. To this date, all medications against SARS-CoV-2 are administered only by infusion and only in severe disease cases [...]
by santiagola
Fighting viruses with nucleotide prodrugs at Santiago Lab
October 11, 2021|Antivirals, Nucleosides | 4 Min Read
During the course of the last decades, outstanding efforts were devoted to design and develop nucleotide prodrugs to be employed as potential therapeutic agents, especially for the treatment of human […]
by santiagola